Grifols’ AMBAR Study Findings: Albumin Plasma Exchange May Reduce Progression of Moderate Alzheimer’s Disease
Findings from Grifols’ Phase IIb Alzheimer Management by Albumin Replacement (AMBAR) clinical trial found long-term plasmapheresis with albumin replacement reduced disease progression in a prespecified subset of patients with AD of moderate severity.
Study Finds Vaccines Don’t Weaken Babies’ Immune Systems
Researchers conducted a study that examined whether the childhood vaccine schedule was associated with an increased risk of infections not targeted by vaccines.
Study Finds Asthma Treatments for Kids More Likely to Fail Without Flu Shot
New research shows an annual influenza (flu) shot is crucial for children with asthma.
Heart Failure Death Risk Drops 50% in Those Who Receive Flu Vaccine
A new study shows people with heart failure who receive a seasonal influenza (flu) vaccine have a 50 percent drop in the risk of death during flu season and a 20percent drop in the risk of death during the rest of the year.
Immune System Response Discovery in Newborns Could Lead to Earlier Vaccine Administration
Researchers at the TCD School ofMedicine and the National Children’sResearch Centre in Ireland have discovered a distinct immune response in newborns that could lead to both earlier vaccine administration and reduced need for multiple booster shots.
Current Pertussis Vaccine Mounts a Weaker Recall Response with Booster Shots
Researchers at the La Jolla Institute for Allergy and Immunology have found individuals who had been inoculated with the newer pertussis (whooping cough) vaccine as part of their initial series of shots mount a weaker recall response when receiving booster shots later on.
The Future of Cord Blood
Once thought to be a useless byproduct, umbilical cord blood now treats more than 80 diseases, and it may soon be used to treat more.
Vaccines in the Pipeline
Research is paving the way for new preventive vaccines for many different illnesses.
New Pill May Kill the Flu Virus in Patients in 24 Hours
Japanese drug maker Shionogi has created an experimental compound delivered via a single-dose pill that has been shown to effectively kill the influenza (flu) virus in patients within a single day.
Plasma Exchange with 5% Albumin Associated with Marked Stabilization of Brain Perfusion in Alzheimer’s
Plasma exchange with 5% albumin replacement was associated with marked stabilization of brain perfusion in patients with mild to moderate Alzheimer’s disease during a 21-week treatment period and reduced perfusion loss compared to control subjects at six-month follow up, according to findings from a sham-controlled Phase II clinical trial.
